Kengo Fujiwara
Papers
2
Total Citations
6
H-Index
1
About
Kengo Fujiwara is a urologic oncologist whose research centers on refining risk stratification and surgical outcomes in prostate cancer. His work focuses on the critical interplay between biopsy pathology and final pathology after radical prostatectomy, particularly for patients with intermediate- to high-risk Gleason scores. Fujiwara’s key contributions include demonstrating that the proportion of Gleason pattern 4 on biopsy is a clinically significant predictor of pathological downgrading after prostatectomy—a finding that helps tailor treatment decisions and avoid overtreatment. His 2021 study on this topic has been cited 5 times, establishing a foundation for more nuanced risk assessment. More recently, Fujiwara has explored nerve-sparing robotic-assisted radical prostatectomy, evaluating whether the absence of PI-RADS ≥3 lesions or Gleason pattern ≥4 on biopsy in the peripheral zone can safely guide surgical technique to preserve erectile function without compromising oncological control. This 2025 work, already cited once, addresses a pressing clinical question: how to maximize quality of life while maintaining cancer clearance. Fujiwara’s research bridges diagnostic pathology and surgical precision, offering actionable insights for urologists and patients navigating prostate cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2